Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2022 Jan;17(1):65-74.
doi: 10.2215/CJN.07810621. Epub 2021 Nov 3.

Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes

Affiliations
Multicenter Study

Using a Multi-Institutional Pediatric Learning Health System to Identify Systemic Lupus Erythematosus and Lupus Nephritis: Development and Validation of Computable Phenotypes

Scott E Wenderfer et al. Clin J Am Soc Nephrol. 2022 Jan.

Abstract

Background and objectives: Performing adequately powered clinical trials in pediatric diseases, such as SLE, is challenging. Improved recruitment strategies are needed for identifying patients.

Design, setting, participants, & measurements: Electronic health record algorithms were developed and tested to identify children with SLE both with and without lupus nephritis. We used single-center electronic health record data to develop computable phenotypes composed of diagnosis, medication, procedure, and utilization codes. These were evaluated iteratively against a manually assembled database of patients with SLE. The highest-performing phenotypes were then evaluated across institutions in PEDSnet, a national health care systems network of >6.7 million children. Reviewers blinded to case status used standardized forms to review random samples of cases (n=350) and noncases (n=350).

Results: Final algorithms consisted of both utilization and diagnostic criteria. For both, utilization criteria included two or more in-person visits with nephrology or rheumatology and ≥60 days follow-up. SLE diagnostic criteria included absence of neonatal lupus, one or more hydroxychloroquine exposures, and either three or more qualifying diagnosis codes separated by ≥30 days or one or more diagnosis codes and one or more kidney biopsy procedure codes. Sensitivity was 100% (95% confidence interval [95% CI], 99 to 100), specificity was 92% (95% CI, 88 to 94), positive predictive value was 91% (95% CI, 87 to 94), and negative predictive value was 100% (95% CI, 99 to 100). Lupus nephritis diagnostic criteria included either three or more qualifying lupus nephritis diagnosis codes (or SLE codes on the same day as glomerular/kidney codes) separated by ≥30 days or one or more SLE diagnosis codes and one or more kidney biopsy procedure codes. Sensitivity was 90% (95% CI, 85 to 94), specificity was 93% (95% CI, 89 to 97), positive predictive value was 94% (95% CI, 89 to 97), and negative predictive value was 90% (95% CI, 84 to 94). Algorithms identified 1508 children with SLE at PEDSnet institutions (537 with lupus nephritis), 809 of whom were seen in the past 12 months.

Conclusions: Electronic health record-based algorithms for SLE and lupus nephritis demonstrated excellent classification accuracy across PEDSnet institutions.

Keywords: PEDSnet; children; health education; learning health system; lupus nephritis; multi-institutional systems; pediatrics; systemic lupus erythematosus.

PubMed Disclaimer

Figures

None
Graphical abstract
Figure 1.
Figure 1.
Final computable phenotype algorithms for SLE and lupus nephritis (LN) both include utilization and diagnostic criteria. Seven-institution data are shown.

References

    1. Sule S, Fivush B, Neu A, Furth S: Increased risk of death in pediatric and adult patients with ESRD secondary to lupus. Pediatr Nephrol 26: 93–98, 2011 - PMC - PubMed
    1. Sule S, Fivush B, Neu A, Furth S: Increased risk of death in African American patients with end-stage renal disease secondary to lupus. Clin Kidney J 7: 40–44, 2014 - PMC - PubMed
    1. Hiraki LT, Feldman CH, Liu J, Alarcón GS, Fischer MA, Winkelmayer WC, Costenbader KH: Prevalence, incidence, and demographics of systemic lupus erythematosus and lupus nephritis from 2000 to 2004 among children in the US Medicaid beneficiary population. Arthritis Rheum 64: 2669–2676, 2012 - PMC - PubMed
    1. Wenderfer SE, Ruth NM, Brunner HI: Advances in the care of children with lupus nephritis. Pediatr Res 81: 406–414, 2017 - PubMed
    1. Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM: Juvenile-onset systemic lupus erythematosus: Update on clinical presentation, pathophysiology and treatment options. Clin Immunol 209: 108274, 2019 - PubMed

Publication types